News

Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Novavax swings to profit, says talks with FDA on COVID vaccine approval ongoing
Novavax said on Thursday discussions with the U.S. health regulator on its COVID-19 shot are ongoing and a pathway to ...
Critic of drug industry and COVID-19 measures to lead FDA vaccine program
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...
FDA names outspoken Covid vaccine critic as the new vaccine chief
Dr. Vinay Prasad was an outspoken critic of the FDA’s response to the pandemic, including the former vaccine chief, Dr. Peter ...
US FDA advisers to discuss COVID-19 vaccine recommendations on May 22
The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts on May 22 to discuss COVID-19 ...
FDA taps critic of COVID policies, drug industry to lead vaccines division
The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...
BioSpace8h
FDA Vaccine Advisors To Meet for COVID-19 Vaccine Updates
The independent experts will meet on May 22 to discuss updates to the COVID-19 vaccine for the upcoming season.
WTAP8m
Moderna study shows immune response in older adults for a combo flu and COVID-19 shot
(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S.
COVID boosters might not be updated for next season, FDA commissioner says
The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical ...
BioPharma Dive1d
FDA set to meet this month on COVID vaccines
The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but ...
CBS News2d
FDA picks critic of COVID boosters to be new top vaccines official
Prasad has long criticized the FDA for granting emergency use authorization for COVID-19 vaccine boosters, saying last year that Marks was "either incompetent or corrupt to authorize a booster ...